RecallDepth
Class II Terminated

Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960

This recall has been terminated (originally issued May 6, 2015).

Company
Teva Pharmaceuticals Usa
Recall Initiated
April 13, 2015
Posted
May 6, 2015
Recall Number
D-0971-2015
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Horsham, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

Distribution

Nationwide

Lot / Code Info

Lot #: a) 6A208123, Exp 8/2015; b) 6A208121, Exp 8/2015.

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls